Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2017-01-26 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
2017年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2017 年第一次临时股东大会会议资料" which translates to "2017 First Extraordinary General Meeting (EGM) Meeting Materials". It contains detailed agenda, meeting rules, voting procedures, and proposals to be voted on, including amendments to the company charter and election of a board member. The content is clearly materials prepared for a shareholders meeting, not the announcement of voting results or a proxy solicitation. It is not a full annual or interim report, nor an earnings release or audit report. The document is a presentation or information packet for the shareholders to review before or during the meeting. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting.
2017-01-26 Chinese
云南云药企业管理咨询服务有限公司拟将其拥有的房屋建筑物（不含土地使用权）处置给昆明中药厂有限公司评估项目资产评估报告
Regulatory Filings Classification · 100% confidence The document text contains only repeated phrases 'Scanned by CamScanner' and no substantive content or financial information. The document length is very short (198 characters), indicating it is not a report or detailed filing. There is no indication of any report type, regulatory body, or financial data. Given the lack of content, this document does not fit any specific report category and should be classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without meaningful content.
2017-01-25 Chinese
关于使用2015年非公开发行股票募集资金临时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Kunming Pharmaceutical Group Co., Ltd. regarding the temporary use of idle funds raised from a 2015 non-public stock issuance to supplement working capital. It details the amount, approval by the board and supervisory committees, compliance with regulatory requirements, and opinions from independent directors and the sponsor institution. The document is relatively short (2931 characters) and focuses on the use of previously raised capital rather than presenting financial statements or comprehensive financial data. It is an update on capital usage and financing activities, specifically about the use of raised funds, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim report, audit report, or earnings release, nor is it a regulatory filing or report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2017-01-25 Chinese
独立董事关于提名夏军先生为公司董事候选人的独立意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing their opinion on the nomination of a candidate for the company's board of directors. It references nomination procedures and qualifications for a board candidate, which aligns with announcements related to board or management changes. There is no financial data, report publication, or voting results. Therefore, this document fits best under Board/Management Information (MANG). The document is short and focused on management nomination, not a report or announcement of voting results.
2017-01-25 Chinese
八届十二次监事会决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from Kunming Pharmaceutical Group Co., Ltd. regarding a resolution passed by the Supervisory Board about the temporary use of funds raised from a 2015 private placement of shares to supplement working capital. It includes details about the meeting, voting, and compliance with relevant regulations. The content is an official announcement of a board resolution related to capital use and financing activities, not a full financial report or audit. It is not a report publication announcement or certification. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on a financing decision, supporting this classification.
2017-01-25 Chinese
独立董事关于使用2015年非公开发行股票募集资金临时补充流动资金的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent director's opinion on the use of funds raised from a 2015 non-public stock issuance for temporary working capital supplementation. It references regulatory guidelines and confirms compliance and reasonableness of the fund usage. The document is a formal opinion related to capital use and fundraising activities, not a full financial report or earnings release. It is not a report publication announcement or certification letter but a specific update on capital usage. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short but contains substantive content about capital use, not just an announcement or certification.
2017-01-25 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.